99 related articles for article (PubMed ID: 16044960)
1. [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Tominaga T; Nomura Y; Horikoshi N; Takashima S; Kimura M; Koyama H; Kikkawa N; Toge T; Mitsuyama S; Morimoto T; Enomoto K; Wada T; Kimishima I; Niitani H;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):983-90. PubMed ID: 16044960
[TBL] [Abstract][Full Text] [Related]
2. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section].
Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y
Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337
[TBL] [Abstract][Full Text] [Related]
3. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)].
Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S
Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338
[TBL] [Abstract][Full Text] [Related]
4. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
[TBL] [Abstract][Full Text] [Related]
5. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
[TBL] [Abstract][Full Text] [Related]
6. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
7. [Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group].
Niitani H; Furuse K; Fukuoka M; Hasegawa K; Taguchi T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):177-87. PubMed ID: 8311488
[TBL] [Abstract][Full Text] [Related]
8. [Early phase II clinical study of KW-2307 in patients with lung cancer. Lung Cancer Section in KW-2307 Study Group].
Furuse K; Ohta M; Fukuoka M; Kurita Y; Kobayashi K; Hasegawa K; Kimura I; Fujii M; Yoshida S; Kitamura S
Gan To Kagaku Ryoho; 1994 May; 21(6):785-93. PubMed ID: 8185336
[TBL] [Abstract][Full Text] [Related]
9. [Late phase II clinical study of KW-2307 in previously untreated patients with non-small cell lung cancer. KW-2307 Study Group (Lung Cancer Group)].
Furuse K; Kinuwaki E; Motomiya M; Nishiwaki H; Hasegawa K; Kobayashi K; Kurita Y; Ohta K; Fukuoka M; Nakajima S
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1941-7. PubMed ID: 8085845
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
11. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
[TBL] [Abstract][Full Text] [Related]
12. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
13. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
Taguchi T; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1915-24. PubMed ID: 9797814
[TBL] [Abstract][Full Text] [Related]
14. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
[TBL] [Abstract][Full Text] [Related]
16. [A late phase II study of CPT-11 (irinotecan) in advanced breast cancer. CPT-11 Study Group on Breast Cancer].
Taguchi T; Tominaga T; Ogawa M; Ishida T; Morimoto K; Ogawa N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1017-24. PubMed ID: 8210251
[TBL] [Abstract][Full Text] [Related]
17. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
[TBL] [Abstract][Full Text] [Related]
18. A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.
Twelves CJ; Dobbs NA; Curnow A; Coleman RE; Stewart AL; Tyrrell CJ; Canney P; Rubens RD
Br J Cancer; 1994 Nov; 70(5):990-3. PubMed ID: 7947109
[TBL] [Abstract][Full Text] [Related]
19. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
Inuyama Y; Kataura A; Togawa K; Saijo S; Satake B; Takeoda S; Konno A; Ebihara S; Sasaki Y; Kida A; Kanzaki J; Ichikawa G; Kono N; Moriyama H; Kamata S; Miyake H; Sakai M; Horiuchi M; Kubota A; Tsukuda M; Matsuura H; Baba S; Saito H; Matsunaga T; Taguchi T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):107-16. PubMed ID: 9987506
[TBL] [Abstract][Full Text] [Related]
20. [Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients].
Yamamoto M; Ariyoshi Y; Hasegawa K; Kobayashi K; Fukuoka M; Kurita Y; Sakuma A; Furuse K; Niitani H
Gan To Kagaku Ryoho; 1994 Jun; 21(7):993-9. PubMed ID: 8002639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]